Manufacturer record
Mascot Health Series Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
40 batches manufactured by Mascot Health Series Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between December 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
40 records linked to Mascot Health Series Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
40Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
40
NSQ batches since 2019
37
Products affected
Assay
Most common failure
Jun 2026
Latest alert
Flagged batches per year
2019 · 12020 · 82021 · 62022 · 42023 · 122024 · 42025 · 42026 · 1
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cilnidipine Tablets IP 10 mg | MT261003Mfg 2026-04 · Exp 2028-03 | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL, GuwahatiState lab | Jun 2026 |
| Atorvastatin & Clopidogrel Tablets | MT251814Mfg 2025-06 · Exp 2027-05 | The sample received does not conform to Manufacturers specification with respect to the test of Atorvasatin assay.Assay | CDTL, MumbaiCDSCO lab | Nov 2025 |
| Fenofibrate Tablets I.P. 160 mg | MT250955Mfg 2025-03 · Exp 2027-02 | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Fenofibrate.Dissolution | RDTL, GuwahatiCDSCO lab | Oct 2025 |
| Telso 80 (Telmisartan Tab I.P.) | MT2321 76Mfg 2023-06 · Exp 2025-05 | Does not conform to I.P.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab | Mar 2025 |
| Sitagliptin Phoshpate Tablets I.P. (50 mg) | MT243714Mfg 2024-11 · Exp 2026-10 | Assay of Sitagliptin PhosphateAssay | CDL KolkataCDSCO lab | Feb 2025 |
| Rosuvastatin, Aspirin & Clopidogrel Capsules (20mg/75mg/75 mg) | MC240184Mfg 2024-02 · Exp 2026-01 | Sample does not conform to Label claim with respect to the content of Aspirin and to Schedule V of Drugs and Cosmetics Act, with respect to free Salicylic Acid.Labelling | DTL ChennaiState lab | Dec 2024 |
| Gabapentin Tablets IP (Gabon-300) | MT225040Mfg 2022-11 · Exp 2024-10 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Apr 2024 |
| Cilnidipine Tablets IP (Cinatab -10) | MT223472AMfg 2022-07 · Exp 2024-06 | DissolutionDissolution | CDL KolkataCDSCO lab | Apr 2024 |
| Lactic Acid Bacillus Tablets 60 Million Spores | MT230908Mfg 2023-03 · Exp 2025-02 | Assay of Gram positive endospore bearing rod shaped bacteriumAssay | CDL KolkataCDSCO lab | Mar 2024 |
| Clopidogrel & Aspirin Tablets IP (75mg / 75mg) | MT221335Mfg 2022-04 · Exp 2024-03 | Related Substances Free Salicylic Acid, Assay for Clopidogrel & DescriptionAssay | CDTL MumbaiCDSCO lab | Dec 2023 |
| Prebiotic & Probiotic Capsules (Floroquik) | MC230548Mfg 2023-07 · Exp 2024-12 | Assay of total gram positive rod shaped bacterium proposed to be total lactobacillus speciesAssay | CDL KolkataCDSCO lab | Nov 2023 |
| Diphenhydramine Hydrochloride, Ammonium Chloride, Sodium Citrate & Menthol Syrup | ML220730Mfg 2022-12 · Exp 2024-11 | Assay/content of MentholAssay | CDL KolkataCDSCO lab | Nov 2023 |
| Ursodeoxycholic Acid Tablets IP (Mascholic- 300) | MT223471Mfg 2022-07 · Exp 2024-06 | DescriptionDescription | CDL KolkataCDSCO lab | Oct 2023 |
| GLIMEPIRIDE TABLETS I.P. (2 mg.) | MT224871Mfg 2022-10 · Exp 2024-09 | DescriptionDescription | RDTL GuwahatiState lab | Oct 2023 |
| Selamer-400 Tablets (Sevelamer Carbonate Tablets 400 mg) | MT22612 4BMfg 2022-12 · Exp 2024-11 | DescriptionDescription | CDL KolkataCDSCO lab | Aug 2023 |
| Aluminium Hydroxide (0.291 gm), Magnesium Hydroxide (98 mg) and Oxetacaine (10 mg )Gel | ML22076 1Mfg 2022-11 · Exp 2024-10 | Assay of OxetacaineAssay | RDTL ChandigarhCDSCO lab | Jul 2023 |
| Aluminium Hydroxide (0.291 gm), Magnesium Hydroxide (98 mg) and Oxetacaine (10 mg ) Gel | ML220582Mfg 2022-10 · Exp 2024-09 | Assay of OxetacaineAssay | RDTL ChandigarhCDSCO lab | Jun 2023 |
| Aceclofenac Tablets I.P. (100 mg) | MT224501Mfg 2022-10 · Exp 2024-09 | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2023 |
| Gabon-300 Tablets (Gabapentin Tablets I.P.) | MT225040Mfg 2022-11 · Exp 2024-10 | Related SubstancesRelated substances | CDTL KolkataCDSCO lab | Mar 2023 |
| Rabomas - DSR (Rabeprazole Sodium & Domperidone (SR) Capsules) | MC22800Mfg 2022-08 · Exp 2024-07 | Assay & Dissolution of Rabeprazole SodiumAssay | CDL KolkataCDSCO lab | Feb 2023 |
| Cildapin 10 Tablets (Cilnidipine Tablets IP) | MT223472BMfg 2022-07 · Exp 2024-06 | DissolutionDissolution | CDL KolkataCDSCO lab | Feb 2023 |
| Ramipril Tablets IP (Ramichek 5 Tablets) | MT214919Mfg 2021-11 · Exp 2023-10 | Assay and Dissolution of Ramipril Tablets IP (Ramichek 5 Tablets)Assay | RDTL ChandigarhCDSCO lab | Dec 2022 |
| Uriflo -D (Tamsulosin HCl & Dutasteride Tablets) | MT223309Mfg 2022-07 · Exp 2024-06 | Uniformity of Content of Tamsulosin HydrochlorideUniformity of weight/content | CDL KolkataCDSCO lab | Oct 2022 |
| Telmisartan Tablets IP 80mg | MT212218Mfg 2021-06 · Exp 2023-05 | DissolutionDissolution | RDTL GuwahatiState lab | May 2022 |
| Itraconazole Capsules 200 mg | MC21250Mfg 2021-04 · Exp 2023-03 | DisintegrationDisintegration | RDTL ChandigarhCDSCO lab | Jan 2022 |
| Trypsin Chymotrypsin Tablets | MT193963Mfg 2020-02 · Exp 2022-01 | Disintegration testDisintegration | CDTL MumbaiCDSCO lab | Dec 2021 |
| Colchicine 0.5 Tablets (Colchicine Tablets I.P. 0.5 mg) | MT201577Mfg 2020-07 · Exp 2022-06 | Related SubstancesRelated substances | CDL KolkataCDSCO lab | Dec 2021 |
| Calcium Carbonate, Magnesium Oxide, Manganese Sulphate, Zinc & Vitamin D3 Tablets | MT191327Mfg 2019-08 · Exp 2021-07 | Assay of Vitamin D3Assay | RDTL GuwahatiCDSCO lab | Jul 2021 |
| REVOL-CC (Calcium Carbonate, Magnesium Oxide, Manganese Sulphate, Zinc & Vitamin D3 Tablets) | MT191326Mfg 2019-08 · Exp 2021-07 | Assay of Vitamin D3Assay | CDTL MumbaiCDSCO lab | Apr 2021 |
| Revol-CC (Calcium Carbonate Magnesium Oxide, Manganese Sulphate, Zinc & Vitamin D3 Tablets) | MT191325Mfg 2019-08 · Exp 2021-07 | Assay of Vitamin D3Assay | CDTL MumbaiCDSCO lab | Feb 2021 |
| Omecot Capsules (Omperazole Capsules IP) | MC 19235Mfg 2019-08 · Exp 2021-07 | Assay & DissolutionAssay | CDTL MumbaiCDSCO lab | Jan 2021 |
| Cystecot-600 (N - Acetylcysteine Tablets) | MT191313Mfg 2019-08 · Exp 2021-07 | AssayAssay | CDTL MumbaiCDSCO lab | Dec 2020 |
| Hebose-50 (Acarbose Tablets IP 50 mg) | MT190814Mfg 2019-06 · Exp 2021-05 | Dissolution & AssayAssay | CDTL MumbaiCDSCO lab | Nov 2020 |
| Glimas-1,Glimepiride Tablets I.P. 5mg | MT191240Mfg 2019-08 · Exp 2021-07 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2020 |
| Verticot ? 8 Tablets (Betahistine DiHCL Tablets I.P.) | MT191390Mfg 2019-08 · Exp 2021-07 | Assay & DissolutionAssay | CDL KolkataCDSCO lab | Oct 2020 |
| Glimepiride Tablets I.P. 2mg. | MT182240Mfg 2019-02 · Exp 2021-01 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2020 |
| Mometran Cream (Mometasone Furoate Cream IP) | 716Mfg 2019-06 · Exp 2021-07 | AssayAssay | CDTL MumbaiCDSCO lab | Jun 2020 |
| Glicot -60 (Gliclazide Extended release Tablets 60 mg) | MT190903Mfg 2019-07 · Exp 2021-06 | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2020 |
| Sucralfate and Oxetacaine Suspension ( SUCRACE-O SUSPENSION ) | ML190359Mfg 2019-09 · Exp 2021-08 | Assay of OxetacaineAssay | RDTL ChandigarhCDSCO lab | Feb 2020 |
| Enbilol (Nebivolol Hydrochloride Tablets I.P. 5 mg) | MT190877Mfg 2019-06 · Exp 2021-05 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.